3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER
2
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Obesity
14
Polycystic Ovary Syndrome
6
Sexual Dysfunction, Physiological
3
Mucositis
3
Endometrial Neoplasms
3
Rectal Neoplasms
2
Overweight
2
Obesity, Morbid
2
Neoplasms
2
Insulin Resistance
2
Head and Neck Neoplasms
2
Dyspnea
2
Chemotherapy-induced Peripheral Neuropathy
2
Breast Neoplasms
2
Vitamin D Deficiency
1
Urinary Incontinence
1
Transfusion-Related Acute Lung Injury
1
Stomach Neoplasms
1
Spondylitis, Ankylosing
1
Smoking
1
Radiation Induced Oral Mucositis
1
Pulmonary Edema
1
Pulmonary Disease, Chronic Obstructive
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Opioid-Induced Constipation
1
Nutrition Disorders
1
Noncommunicable Diseases
1
Lymphoma, Follicular
1
Intestinal Diseases
1
Infertility
1
Interventions
Alginates
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Esophagitis
×
Other
×
Clear all
NCT06958445
2025-05-06
SAFE
Taipei City Hospital
Phase 2
Enrolling by invitation
90 enrolled